Many cancer treatments were developed for adult physiology, not pediatric biology, resulting in disproportionate long-term ...

Empowering Tomorrow Through the Strength of Awareness DENVER, CO, UNITED STATES, March 9, 2026 /EINPresswire.com/ -- On ...

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

The Prostate Cancer Foundation (PCF) today announced a $10 million unrestricted gift from an anonymous donor to launch a TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award, which will ...

More than $1.1 million in new provincial funding is accelerating cancer research in Sudbury, supporting a homegrown technology that could change how oncologists assess chemotherapy effectiveness.

The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...

Participants will be given a pathology request form and can have the blood test done at a convenient collection centre or at ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.